Clinical Trial Update: Trial of Ampakine Added to Clozapine, Olanzapine or Risperidone in Patients With Schizophrenia [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial investigated adding an ampakine to clozapine, olanzapine, or risperidone in patients with schizophrenia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Ampakine
• Clozapine (Clozapine)
• RISPERIDONE (RISPERIDONE)
• olanzapine (olanzapine)

Snippet

Sponsor: North Suffolk Mental Health Association | Conditions: Schizophrenia | Phase 2, Phase 3 | Status: COMPLETED